Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up.
Jan BergMarina LovrinovicNora BaltenspergerChristine K KisselJan KottwitzRobert MankaDimitri PatrikiFrank ScherffChristian SchmiedUlf LandmesserThomas F LüscherBettina HeideckerPublished in: Open heart (2019)
This is the first case-control study demonstrating that NSAIDs are safe in patients with myopericarditis and preserved LVEF. Our data suggest that this drug class should be tested prospectively in a large randomised clinical trial.
Keyphrases
- clinical trial
- anti inflammatory drugs
- anti inflammatory
- open label
- double blind
- liver failure
- study protocol
- drug induced
- phase ii
- respiratory failure
- electronic health record
- big data
- phase iii
- placebo controlled
- randomized controlled trial
- aortic dissection
- intensive care unit
- extracorporeal membrane oxygenation
- hepatitis b virus
- data analysis
- machine learning
- artificial intelligence
- adverse drug
- acute respiratory distress syndrome
- mechanical ventilation